Amgen Inc.
AMGN
$285.98
$4.571.62%
| Weiss Ratings | AMGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Good | |||
| Risk Index | Fair | |||
| Risk Grade | C- | |||
| Reward Grade | B- | |||
| Rating Factors | AMGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Good | |||
| Growth Index | Weak | |||
| Efficiency Index | Excellent | |||
| Solvency Index | Good | |||
| Total Return Index | Fair | |||
| Volatility Index | Fair | |||
| Beta / Standard Deviation | AMGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.33 | |||
| Price History | AMGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -6.45% | |||
| 30-Day Total Return | -7.17% | |||
| 60-Day Total Return | 7.19% | |||
| 90-Day Total Return | 1.91% | |||
| Year to Date Total Return | 11.19% | |||
| 1-Year Total Return | 9.15% | |||
| 2-Year Total Return | 21.16% | |||
| 3-Year Total Return | 25.28% | |||
| 5-Year Total Return | 52.78% | |||
| 52-Week High % Change | -18.87% | |||
| 52-Week Low % Change | 11.10% | |||
| Price | AMGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $346.85 | |||
| 52-Week Low Price | $253.30 | |||
| 52-Week Low Price (Date) | Dec 19, 2024 | |||
| 52-Week High Price (Date) | Jul 25, 2024 | |||
| Valuation | AMGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 151.30B | |||
| Enterprise Value | 200.21B | |||
| Price/Earnings (TTM) | 37.29 | |||
| Earnings Per Share (TTM) | 7.55 | |||
| Earnings Per Share Growth | -39.60% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 4.56 | |||
| Price/Book (Q) | 25.71 | |||
| Enterprise Value/Revenue (TTM) | 5.99 | |||
| Price | $285.98 | |||
| Enterprise Value/EBITDA (TTM) | 13.21 | |||
| Enterprise Value/EBIT | 20.69 | |||
| Market Cap Category | Large Cap | |||
| Dividends and Shares | AMGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 542.00M | |||
| Dividend Yield | 3.24% | |||
| Div. Per Share (Most Recent) | $2.38 | |||
| Dividend Per Share (TTM) | $9.13 | |||
| Payout Ratio (TTM) | 118.14% | |||
| Dividend Per Share (Most Recent) | $2.38 | |||
| Company Info | AMGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 805 447 1000 | |||
| Address | One Amgen Center Drive Thousand Oaks, CA 91320-1799 | |||
| Website | www.amgen.com | |||
| Country | United States | |||
| Year Founded | 1980 | |||
| Profitability | AMGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 28.94% | |||
| Profit Margin | 12.23% | |||
| Management Effectiveness | AMGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 6.40% | |||
| Return on Equity | 67.55% | |||
| Income Statement | AMGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 32.03B | |||
| Total Revenue (TTM) | 33.42B | |||
| Revenue Per Share | $61.67 | |||
| Gross Profit (TTM) | 22.97B | |||
| EBITDA (TTM) | 15.16B | |||
| EBIT (TTM) | 9.68B | |||
| Net Income (TTM) | 4.09B | |||
| Net Income Avl. to Common (TTM) | 4.09B | |||
| Total Revenue Growth (Q YOY) | 10.86% | |||
| Earnings Growth (Q YOY) | -18.25% | |||
| EPS Diluted (TTM) | 7.55 | |||
| EPS Diluted Growth (Q YOY) | -18.73% | |||
| Balance Sheet | AMGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 11.97B | |||
| Cash Per Share (Q) | $22.09 | |||
| Total Current Assets (Q) | 29.03B | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 5.88B | |||
| Current Ratio (Q) | 1.257 | |||
| Book Value Per Share (Q) | $10.95 | |||
| Total Assets (Q) | 91.84B | |||
| Total Current Liabilities (Q) | 23.10B | |||
| Total Debt (Q) | 60.88B | |||
| Total Liabilities (Q) | 85.96B | |||
| Total Common Equity (Q) | 5.88B | |||
| Cash Flow | AMGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -1.05B | |||
| Cash from Financing (TTM) | -9.42B | |||
| Net Change in Cash (TTM) | 1.03B | |||
| Levered Free Cash Flow (TTM) | 13.43B | |||
| Cash from Operations (TTM) | 11.49B | |||
